362 related articles for article (PubMed ID: 7349093)
1. Preliminary evaluation of immunotherapy in patients with Hodgkin's disease.
Zywicka-Lopaciuk H; Konopka L; Karpowicz M; Sylwestrowicz T; Maślanka K; Arczyńska-Brojer E; Cieśluk S; Małkowska-Zwierz W; Pawelski S
Arch Immunol Ther Exp (Warsz); 1981; 29(6):739-55. PubMed ID: 7349093
[TBL] [Abstract][Full Text] [Related]
2. Management of advanced Hodgkin's disease in remission.
Klener P; Hausner P; Donner L
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):213-7. PubMed ID: 6179821
[TBL] [Abstract][Full Text] [Related]
3. Levamisole in the treatment of Hodgkin's disease.
Berényi E; Kávai M; Szabolcsi M; Szegedi G
Acta Med Acad Sci Hung; 1979; 36(2):177-85. PubMed ID: 317549
[TBL] [Abstract][Full Text] [Related]
4. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
Levo Y; Rotter V; Ramot B
Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352
[TBL] [Abstract][Full Text] [Related]
5. [BCG immunotherapy in malignant lymphogranuloma].
Dientsbier Z; Foltýnová V; Hermanská Z; Chytrý P; Maríková E
Sb Lek; 1991 May; 93(3-4):84-94. PubMed ID: 1853142
[TBL] [Abstract][Full Text] [Related]
6. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
Lang JM; Bigel P; Oberling F; Mayer S
Pathol Biol (Paris); 1978; 26(3-4):159-62. PubMed ID: 355984
[TBL] [Abstract][Full Text] [Related]
7. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
Lang JM; Bigel P; Oberling F; Mayer S
Sem Hop; 1978 Nov 8-15; 54(37-40):1155-8. PubMed ID: 217096
[TBL] [Abstract][Full Text] [Related]
8. Serum zinc levels, lymphocyte counts and functions in pediatric Hodgkin's disease.
Babacan E; Cavdar AO; Arcasoy A
Boll Ist Sieroter Milan; 1977 Jul; 56(3):228-34. PubMed ID: 901636
[TBL] [Abstract][Full Text] [Related]
9. Cellular immune reactivity in patients with rheumatoid arthritis and effects of levamisole.
Basch CM; Spitler LE; Engleman EG; Engleman EP
J Rheumatol; 1977; 4(4):377-88. PubMed ID: 604477
[TBL] [Abstract][Full Text] [Related]
10. BCG as active immunotherapy in children with acute lymphoblastic leukemia in longstanding remission: positive effects on remission duration and immunologic parameters.
Miale TD; Yocum D; Yocum C
Biomedicine; 1978 May; 28(2):96-104. PubMed ID: 276382
[TBL] [Abstract][Full Text] [Related]
11. BCG vaccination in Hodgkin's lymphogranuloma.
Kolár V; Opat P; Hrdlicková N
Neoplasma; 1979; 26(1):13-6. PubMed ID: 431752
[TBL] [Abstract][Full Text] [Related]
12. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
Churchill WH; Rocklin RR; Moloney WC; David JR
Natl Cancer Inst Monogr; 1973 May; 36():99-106. PubMed ID: 4583000
[No Abstract] [Full Text] [Related]
13. Quantitation of immunocompetence in Hodgkin's disease.
Faguet GB
J Clin Invest; 1975 Oct; 56(4):951-7. PubMed ID: 1159096
[TBL] [Abstract][Full Text] [Related]
14. Effect of levamisole, thymic humoral factor and indomethacin on e-rosette formation of lymphocytes in Hodgkin's disease.
Ramot B; Rosenthal E; Biniaminov M; Ben-Bassat I
Isr J Med Sci; 1981 Apr; 17(4):232-5. PubMed ID: 7195385
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic results in lymphogranulomatosis and their relationship to immunological reactivity].
Dienstbier Z; Foltýnová V; Hlavatý V; Kopricová H; Masopust J
Vopr Onkol; 1981; 27(4):22-6. PubMed ID: 7233870
[TBL] [Abstract][Full Text] [Related]
16. Immune status of untreated patients with Hodgkin's disease and prognosis.
Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
[TBL] [Abstract][Full Text] [Related]
17. [Hodgkin's disease: study of delayed hypersensitivity of 64 non treated patients. Value of epicutaneous test using croton oil].
Goasguen J; Leblay R; Guerin D; Le Prise PY; Richier JL
Sem Hop; 1977 Jan; 53(4):219-25. PubMed ID: 189435
[TBL] [Abstract][Full Text] [Related]
18. Monocyte chemotaxis and effect of levamisole in Hodgkin's disease.
Lukács K; Frendl G; Berényi E; Kávai M; Szabó G; Szegedi G
Acta Med Acad Sci Hung; 1980; 37(2):145-50. PubMed ID: 7457021
[TBL] [Abstract][Full Text] [Related]
19. Effect of levamisole on E-rosette-forming cells in vivo and in vitro in Hodgkin's disease.
Ramot B; Biniaminov M; Shoham C; Rosenthal E
N Engl J Med; 1976 Apr; 294(15):809-11. PubMed ID: 1082545
[TBL] [Abstract][Full Text] [Related]
20. Changes of the cellular immunity tests during the evolution of Hodgkin's disease.
Răileanu-Moţoiu I; Dumitrescu A; Costescu M; Mocanu N; Berceanu S
Med Interne; 1983; 21(3):203-15. PubMed ID: 6665494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
